The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Olomucine     2-[[6-(benzylamino)-9-methyl- purin-2...

Synonyms: olomoucine, UPCMLD-DP136, Lopac-O-0886, Tocris-1284, Kinome_2870, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of olomoucine


High impact information on olomoucine


Chemical compound and disease context of olomoucine


Biological context of olomoucine


Anatomical context of olomoucine


Associations of olomoucine with other chemical compounds


Gene context of olomoucine


Analytical, diagnostic and therapeutic context of olomoucine


  1. Plasma membrane alterations and cytoskeletal changes in apoptosis. van Engeland, M., Kuijpers, H.J., Ramaekers, F.C., Reutelingsperger, C.P., Schutte, B. Exp. Cell Res. (1997) [Pubmed]
  2. Effects of cyclin-dependent kinase inhibitors on transcription and ocular circadian rhythm of Aplysia. Sankrithi, N., Eskin, A. J. Neurochem. (1999) [Pubmed]
  3. Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo. Zhu, Z., Zhang, Q., Yu, Z., Zhang, L., Tian, D., Zhu, S., Bu, B., Xie, M., Wang, W. Glia (2007) [Pubmed]
  4. Transient hypoxia may lead to neuronal proliferation in the developing mammalian brain: from apoptosis to cell cycle completion. Bossenmeyer-Pourié, C., Chihab, R., Schroeder, H., Daval, J.L. Neuroscience (1999) [Pubmed]
  5. Cell cycle inhibition attenuates microglia induced inflammatory response and alleviates neuronal cell death after spinal cord injury in rats. Tian, D.S., Xie, M.J., Yu, Z.Y., Zhang, Q., Wang, Y.H., Chen, B., Chen, C., Wang, W. Brain Res. (2007) [Pubmed]
  6. Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Di Giovanni, S., Movsesyan, V., Ahmed, F., Cernak, I., Schinelli, S., Stoica, B., Faden, A.I. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  7. Cell cycle-dependent phosphorylation of mammalian protein phosphatase 1 by cdc2 kinase. Kwon, Y.G., Lee, S.Y., Choi, Y., Greengard, P., Nairn, A.C. Proc. Natl. Acad. Sci. U.S.A. (1997) [Pubmed]
  8. Pho85p, a cyclin-dependent protein kinase, and the Snf1p protein kinase act antagonistically to control glycogen accumulation in Saccharomyces cerevisiae. Huang, D., Farkas, I., Roach, P.J. Mol. Cell. Biol. (1996) [Pubmed]
  9. Cell cycle-dependent control of polarised development by a cyclin-dependent kinase-like protein in the Fucus zygote. Corellou, F., Brownlee, C., Kloareg, B., Bouget, F.Y. Development (2001) [Pubmed]
  10. The cyclin-dependent kinase (cdk) inhibitors, olomoucine and roscovitine, alter the expression of a molluscan circadian pacemaker. Krucher, N.A., Meijer, L., Roberts, M.H. Cell. Mol. Neurobiol. (1997) [Pubmed]
  11. Differential effects of cyclin-dependent kinase blockers upon cell death in the developing retina. Rehen, S.K., Cid, M., Fragel-Madeira, L., Linden, R. Brain Res. (2002) [Pubmed]
  12. Synergic effects of the cyclin-dependent kinase (CDK) inhibitor olomoucine and androgen-antagonist bicalutamide on prostatic cancer cell lines. Knillová, J., Bouchal, J., Hlobilková, A., Strnad, M., Kolár, Z. Neoplasma (2004) [Pubmed]
  13. A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein. Ratner, N., Bloom, G.S., Brady, S.T. J. Neurosci. (1998) [Pubmed]
  14. Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. Jin, Y.H., Yoo, K.J., Lee, Y.H., Lee, S.K. J. Biol. Chem. (2000) [Pubmed]
  15. CIL-102 interacts with microtubule polymerization and causes mitotic arrest following apoptosis in the human prostate cancer PC-3 cell line. Huang, Y.T., Huang, D.M., Guh, J.H., Chen, I.L., Tzeng, C.C., Teng, C.M. J. Biol. Chem. (2005) [Pubmed]
  16. ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells. Zhang, W., Lee, J.C., Kumar, S., Gowen, M. J. Bone Miner. Res. (1999) [Pubmed]
  17. Evidence that the endogenous histone H1 phosphatase in HeLa mitotic chromosomes is protein phosphatase 1, not protein phosphatase 2A. Paulson, J.R., Patzlaff, J.S., Vallis, A.J. J. Cell. Sci. (1996) [Pubmed]
  18. Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18. Fletcher, A.I., Shuang, R., Giovannucci, D.R., Zhang, L., Bittner, M.A., Stuenkel, E.L. J. Biol. Chem. (1999) [Pubmed]
  19. Mitotic disassembly of the Golgi apparatus in vivo. Misteli, T., Warren, G. J. Cell. Sci. (1995) [Pubmed]
  20. An inhibition of cyclin-dependent kinases that lengthens, but does not arrest, neuroepithelial cell cycle induces premature neurogenesis. Calegari, F., Huttner, W.B. J. Cell. Sci. (2003) [Pubmed]
  21. Cdk5 regulates activation and localization of Src during corneal epithelial wound closure. Gao, C.Y., Stepp, M.A., Fariss, R., Zelenka, P. J. Cell. Sci. (2004) [Pubmed]
  22. Cdk5/p35 and Rho-kinase mediate ephrin-A5-induced signaling in retinal ganglion cells. Cheng, Q., Sasaki, Y., Shoji, M., Sugiyama, Y., Tanaka, H., Nakayama, T., Mizuki, N., Nakamura, F., Takei, K., Goshima, Y. Mol. Cell. Neurosci. (2003) [Pubmed]
  23. Phosphorylation of Sp1 by cyclin-dependent kinase 2 modulates the role of Sp1 in CTP:phosphocholine cytidylyltransferase alpha regulation during the S phase of the cell cycle. Banchio, C., Schang, L.M., Vance, D.E. J. Biol. Chem. (2004) [Pubmed]
  24. Evidence for phosphorylation of CTP:phosphocholine cytidylyltransferase by multiple proline-directed protein kinases. Wieprecht, M., Wieder, T., Paul, C., Geilen, C.C., Orfanos, C.E. J. Biol. Chem. (1996) [Pubmed]
  25. Mitogen-activated protein kinase regulates neurofilament axonal transport. Chan, W.K., Dickerson, A., Ortiz, D., Pimenta, A.F., Moran, C.M., Motil, J., Snyder, S.J., Malik, K., Pant, H.C., Shea, T.B. J. Cell. Sci. (2004) [Pubmed]
  26. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity. Alessi, F., Quarta, S., Savio, M., Riva, F., Rossi, L., Stivala, L.A., Scovassi, A.I., Meijer, L., Prosperi, E. Exp. Cell Res. (1998) [Pubmed]
  27. Modulation of Sp1 activity by a cyclin A/CDK complex. Haidweger, E., Novy, M., Rotheneder, H. J. Mol. Biol. (2001) [Pubmed]
  28. Inhibition of cyclin-dependent kinases by purine analogues. Veselý, J., Havlicek, L., Strnad, M., Blow, J.J., Donella-Deana, A., Pinna, L., Letham, D.S., Kato, J., Detivaud, L., Leclerc, S. Eur. J. Biochem. (1994) [Pubmed]
  29. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors. Atienza, C., Elliott, M.J., Dong, Y.B., Yang, H.L., Stilwell, A., Liu, T.J., McMasters, K.M. Int. J. Mol. Med. (2000) [Pubmed]
  30. Synthetic cyclin dependent kinase inhibitors. New generation of potent anti-cancer drugs. Hajdúch, M., Havlíèek, L., Veselý, J., Novotný, R., Mihál, V., Strnad, M. Adv. Exp. Med. Biol. (1999) [Pubmed]
  31. Identification of plectin as a substrate of p34cdc2 kinase and mapping of a single phosphorylation site. Malecz, N., Foisner, R., Stadler, C., Wiche, G. J. Biol. Chem. (1996) [Pubmed]
  32. Kinase and phosphatase inhibitors cause rapid alterations in microtubule dynamic instability in living cells. Howell, B., Odde, D.J., Cassimeris, L. Cell Motil. Cytoskeleton (1997) [Pubmed]
  33. Hyperphosphorylation at serine 199/202 of tau factor in the gerbil hippocampus after transient forebrain ischemia. Morioka, M., Kawano, T., Yano, S., Kai, Y., Tsuiki, H., Yoshinaga, Y., Matsumoto, J., Maeda, T., Hamada, J., Yamamoto, H., Fukunaga, K., Kuratsu, J. Biochem. Biophys. Res. Commun. (2006) [Pubmed]
  34. Studies of the cell cycle of in vitro cultured skin fibroblasts in goats: work in progress. Yu, Y.S., Sun, X.S., Jiang, H.N., Han, Y., Zhao, C.B., Tan, J.H. Theriogenology (2003) [Pubmed]
  35. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. Abraham, R.T., Acquarone, M., Andersen, A., Asensi, A., Bellé, R., Berger, F., Bergounioux, C., Brunn, G., Buquet-Fagot, C., Fagot, D. Biol. Cell (1995) [Pubmed]
WikiGenes - Universities